Portal Vein Thrombosis Withdrawn Phase Trials for Nadroparin (DB08813)

Also known as: Portal (vein) obstruction / Pylethrombosis / Thrombosis portal vein

IndicationStatusPhase
DBCOND0042200 (Portal Vein Thrombosis)WithdrawnNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02526303Anticoagulation for Non-occlusive Portal Vein Thrombosis in Patients With Liver CirrhosisTreatment